Earnings Feed
Start Free
BIOJECT MEDICAL TECHNOLOGIES INC·4

Oct 4, 9:13 PM ET

Makar Ralph 4

4 · BIOJECT MEDICAL TECHNOLOGIES INC · Filed Oct 4, 2010

Insider Transaction Report

Form 4
Period: 2010-10-01
BIOJECT MEDICAL TECHNOLOGIES INCBJCT
Makar Ralph
CEO/President
Transactions
  • Exercise/Conversion

    BJCT Common Stock

    2010-10-01+33,334→ 827,368 total
  • Exercise/Conversion

    Restricted Stock Unit

    2010-10-01−33,334→ 50,000 total
    From: 2010-10-01→ BJCT Common Stock (33,334 underlying)
Holdings

  • BJCT Common Stock

    (indirect: By 401(k))
    113,930
Footnotes (4)
  • [F1]1/3 vesting per Executive Employment Agreement dated October 1, 2007.
  • [F2]Each Restricted Stock Unit represents a contingent right to receive one share of BJCT Common Stock.
  • [F3]No expiration date.
  • [F4]Includes Series F Preferred Stock 67,600, Warrant 6,667. Option (Right-to-buy) 480,000, Restricted Stock Unit 50,000.

Documents

1 file
  • 4
    primary_doc.xmlPrimary

    PRIMARY DOCUMENT